《大行报告》花旗上调创科(00669.HK)目标价至163元 去年业绩胜预期
花旗发表的研究报告指,创科实业(00669.HK)今年以来订单势头强劲,去年净利按年升30%至8.01亿美元,较市场及该行预期高7%及10%,花旗并将创科2021及2022年盈利预测升8%及6%,目标价由153元升至163元,评级「买入」。
该行指出去年公司收入按年增长28.5%,专业工具方面的增长则为25.8%,DIY/户外业务收入升32%,而地板护理设备则升23.6%,估计经济复苏及1.9万亿美元的经济刺激措施应可抵销原材料成本上升因素有余,留意到今年以来订单势头强劲,主要因为美国零售商及专业工具经销商补货,认为创科为中国工业股首选。
花旗认为利好因数包括欧美经济复苏,料将刺激工程活动并带动专业工具的需求,而美国1.9万亿美元的刺激措施亦料可带动基建及消费,相信相关因素将抵销原材料成本上升及居家抗疫需求减少的影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.